Found 2,855 investors
Doug Schillinger
Park City, Utah, United States
Doug Schillinger Managing Director at DW Healthcare Partners.
Investment Partner
Past Investments
360 Behavioral Health, Diagnostic Ultrasound, Med Pharmex, Aequor Healthcare Services, SoClean, CareXM, Future Finance, Tandem Labs, California Psychcare, Pentec Health, Arteriocyte Medical Systems, Career Step, Emphusion, Cefaly Technology, Prime Education, EHE
Edgar Jannotta
Teton Village, Wyoming, United States
Mr. Jannotta, Jr served until 2011 as Principal and co-manager of the Healthcare Group at GTCR. Since 1980, GTCR has invested more than $9 ...
Individual/Angel
Seed
Past Investments
ArthroMeda, SwervePay, Alcyone Lifesciences
Edward Sohn
Atlanta, Georgia, United States
Healthcare Private Equity Investor at Cobepa
Individual/Angel
Past Investments
Eastern Dental, Anovia Payments, Jazz Pharmaceuticals, PSI Services, Minnesota Eye Consultants, ChiroTouch, The CE Shop, CyberGrants, Adult & Pediatric Dermatology, Pharmacy Partners Holdings
Ela Borenstein
Montreal, Quebec, Canada
Ms. Ela Borenstein serves as Managing Partner at BDC Healthcare Venture. She joined BDC Venture Capital in 2007 and has over 20 years of man...
Investment Partner
Seed
Series A
Past Investments
Hortau, H2O Innovation, Granville Biomedical, Exact Imaging, Peak Power Inc, Cord3, Eigen Innovations, JLD - Laguë, Nicoya Lifesciences, Strato Automation, Borrowell, Verdant Environmental Technologies, SOL Cuisine, Avidbots, Milestone Pharmaceuticals, Metamaterial Inc., MaxSold Incorporated, Periculum, Kenota Health, Lynx Equity, Blue J Legal, Relogix, Delve Security, Charli AI, Local Logic, Skygauge, Aya, Thrasos, Alethia BioTherapeutics, Eavor, Eagle's Flight, Food.ee, Page Zero Media, KorrAI, CSS Group, Reperformance, International Test Pilots School, Deeplite, VMOpro, Sera4, Quadra Plast, Invixium, Vendura Wellness, TickSmith, Fiasco Gelato, Benchmark Instrumentation & Analytical Services, Kute Lab, Book4Time, MICC Financial, Repare Therapeutics, Prophix Software, Sofdesk, ClearRisk, Myplanet, Renaissance Repair and Supply, Vendasta Technologies, CalendarHero, Lube City, ZenHub, Pit Caribou, TickTrade Systems, Nix Sensor, BinSentry, Quorum Information Technologies, Greybox Solutions, Nuvyyo, Preciseley Microtechnology, PAPER, Smooth Meal Prep, Zymeworks, AngioChem, Trulioo, TouchBistro, Aifred Health, ReelData AI, Drillform, Effenco, Verafin, Momentum Technologies, RIDDL, Pixel Union, Budge Studios, Busbud, Foko Retail, K-eCommerce, Tulip Retail, Roomvu, ClaroNav, NanoXplore, Altitude-Sports.com, SuccessFinder, Nemalux Led Lighting, SmartMed, tealbook, Librestream Technologies, Longbow Advantage, Cognibox, Mysa
Eliza Adams
New York, New York
Healthcare Investor at Oak HC/FT
Health & Hospital Services
Health IT
Series B
Past Investments
CLARA analytics, Kasisto, Quartet Health, Notable, LDI, Urjanet, Brightline, VillageMD, Cerebral, Rapyd, DispatchHealth, Unite Us, Core Informatics, Sendoso, AU10TIX, Ethic, CareGuardian, WithMe Health, axialHealthcare, Advise Insurance, Vesta Healthcare, Oncology Analytics, Trōv, Groundspeed Analytics, Maven Clinic, US HealthVest, Galileo Health, NextCapital, Inscripta, Aspire Health, Everside Health, Limeade, Namogoo, Maestro Health, Ocrolus, Digital Currency Group, Devoted Health, Cricket Health, PMI BioPharma Solutions, FastPay, Komodo Health, Circulo Health, Feedzai, Pagaya Investments, CareBridge, Wisetack, Truepill, Sema4, Therapy Brands, OODA Health, Firefly Health, Kryon, Olive, Poynt, Insureon, Panorays
Emilios Markou
United States
Mr. Martin Felsenthal serves as Board Member at Array Behavioral Care. Mr. Martin Felsenthal serves as Partner at Health Velocity Capital. He also serves as a Board Member at WELL Health and Clever Care Health Plan. He served as Board Member at OnShift and MDLive. He has worked exclusively with innovative, disruptive, and rapidly growing healthcare software and services companies for more than 20 years. He was previously a partner at two leading venture and growth capital firms focused on this sector -- Salix Ventures and HLM Venture Partners - and also worked with Madison Dearborn Partners earlier in his career. He has led investments in and/or served on the Boards of Directors of companies such as TelaDoc (NYSE: TDOC); Change Healthcare (acquired by Emdeon); Aperio (acquired by Leica Biosystems); Titan Health (acquired by United Surgical Partners); US Renal Care (acquired by Leonard Green); Payerpath (acquired by Misys/Allscripts); Vantage Oncology (acquired by McKesson); NovoLogix (acquired by CVS Health); VeriCare (acquired by MedOptions);; and ClearData Networks. Marty received his AB from Princeton University and his MBA from the Stanford University Graduate School of Business.
Individual/Angel
Past Investments
Workable, IOVOX, essdocs, Zocdoc, manduka
Eren Bali
San Francisco, California, United States
Eren Bali is the CEO and Co-Founder of Carbon Health. Eren leads the Carbon team towards his vision to democratize healthcare and make quali...
Individual/Angel
Seed
Past Investments
Pvgna
Erik Nierenberg
United States
Mr. Robert Zieserl serves as Chief Executive Officer, President & Board Member at simMachines. He is a Board Observer and Angel Investor at PhysIQ. He was the Chairman and served as Chief Executive Officer at Vital Sensors. He is a Co-Founder and General Partner at Stratus Ventures. He was a Managing Director of KB Partners Venture Fund II at KB Partners, L.L.C. He served as Board Member at Verax Biomedical. He specialized in investments in medical devices, diagnostics, and healthcare informatics. He has over 30 years of management experience growing and investing in healthcare and technology companies. He is well versed in business strategy, product development, marketing, and partnering for early-stage companies. Prior to founding Stratus Ventures, he was a Managing Director of KB Partners, L.L.C., which he joined in 2000. Prior to joining KB Partners, he was a Co-Founder and Managing Director of Gray Drake Partners. He founded Gray Drake Partners after serving as the President and Chief Operating Officer of Software Development Systems, Inc. As the President, he successfully funded, grew, and ultimately sold the company to Wind River Systems, Inc. He also served as the Chief Executive Officer of Tomtec Imaging, Inc. He also led the founding of Tomtec Imaging while an Entrepreneur-in-Residence with Platinum Venture Partners. Earlier in his career, he was the President and Chief Operating Officer of Medicus Systems, Inc., where he was the key to the company's successful IPO. He currently sits on the Board of Directors of Mezzia, Sarvega, Inc., and is a Board Observer at Accumetrics and a Board Member at Endotronix. He is active in a number of professional organizations, including the World Presidents Organization (WPO), where he is the Chairman of the Mentorship Program with the Entrepreneurs Organization (EO). He was a Director at Ischemia Technologies. He received an M.Sc. in Management and Industrial Relations from Loyola University, Chicago, and a B.A. from the Marquette University.
Individual/Angel
Past Investments
Kelvin
Eugene Pozdnikov
San Jose, California, United States
CEO and co-founder at CYBX| Strategy and Solution builder | Healthcare IT |Data Analytics | AI |Unified Data Fabric solutions for the Healthcare vertical.
Medical
Health Care
Individual/Angel
Seed
Past Investments
Doft
Evan Melrose
Austin, Texas, United States
Dr. MelroseвАЩs 24 years in the Healthcare industry includes experience in operating, clinical & investment (both public & private), research,...
Investment Partner
Past Investments
HNI Healthcare, Qspex Technologies
Faysal Sohail
United States
Mr. Antoine Colaço serves as Managing Partner at Valor Capital Group. He serves as Board Member at Dolado and Rocket.Chat. He also is a Board Member at Descomplica, Migo, and BookingPal. He was at Google for 9 years serving in a wide range of capacities. He was most recently COO of Global Partnerships, supporting all of Google's partnerships. Previously, he established Google's India presence by founding its operations in Hyderabad and grew its Latin American presence by launching offices and online AdWords operations in Brazil, Mexico, and Argentina. More recently, he headed the Reseller Channel for Asia-Pacific and LATAM and was the Chief Operating Officer for the APAC and LATAM regions. Prior to joining Google, HE was in Business Development for Yahoo! Finance. Antoine also held roles at Goldman Sachs, Development Bank of Singapore, and CSC Healthcare. He received his BSE, cum laude, from Princeton University, in Mechanical and Aerospace Engineering and a certificate in Public and International Affairs from the Woodrow Wilson School. He also has an MBA from the Harvard Business School.
Individual/Angel
Past Investments
Neos Therapeutics, Nominum, Mojo Networks, Ensim Corporation, Cnano Technology, SurgiQuest, ESS, Marathon Technologies, Wildcat Discovery Technologies, Solaria, VYNE Therapeutics, BlueStacks
Frank Howard
India
Mr. Devang Mehta serves as Partner at Anthill Ventures. He is also an angel investor. He serves as Board Member at AyuRythm. He served as Director, Marketing & Business Development at Glassbeam. He is responsible for various activities in the Fund's operations including structuring, fund marketing, devising fund strategy, Investments and advising portfolio companies on growth strategies. Before joining, Anthill, he has made angel investments in and acted as a strategic adviser to, numerous startups in the Food Tech, IoT, FinTech, Healthcare and other Technology verticals. Prior to his activities in the investing ecosystem, he has more than 2 decades of experience in operational areas at early stage companies in various capacities: Marketing, Corporate Strategy, Sales, Product Management, and Software Development. He has played pivotal roles in commercializing Enterprise products and helping them achieve operational profitability. He has degrees in Computer Science and Engineering and an MBA from Carnegie Mellon University's Tepper School of Business with a concentration in Entrepreneurship and Venture Finance.
Individual/Angel
Seed
Past Investments
Owlized
Fusion Fund
Palo Alto, California, United States
Fusion Fund invests in early stage companies with technological and data advantages in industrial, enterprise, and healthcare applications.
Finance
Financial Services
Venture Capital
Micro VC
Venture Capital
Past Investments
codeSpark, Priime, POC Medical Systems, BlueFoxio, Constructorio, Popular Pays, AMPY, Shift Messenger, Gamma2robotics, DreamAlliance Entertainment, Catalia Health, Roost, MedWhat, Cuseum Techstars 15, Grub Market, Paperspace, Bagaveev, NuCypher
Gary Abrahams
North Carolina, United States, North America
Gary Abrahams has 30 years of sales, marketing, product management, business and market development experience in the healthcare industry fo...
Investment Partner
Past Investments
CarePort Health, USARAD, Bivarus, Health Decisions, Jumo Health, Diameter Health, Elligo Health Research, OrbitalRx, Censinet, NurseGrid, Oculus Health
Gary Stevenson
Memphis, Tennessee, United States
Gary Stevenson co-founded MB Venture Partners in 2001 after six years in healthcare investment banking and equity research. Previously, ...
Investment Partner
Past Investments
HandMinder, Spine Wave, Restore Medical Solutions, Alveolus, Veracity Medical Solutions, Innometrix, BioNanovations, Cast21, Zyga Technology, Kereos, Anulex Technologies, Brainsgate, Cayenne Medical, Ortho Kinematics, iScreen Vision, S2 Interactive, Salient Surgical Technologies, SweetBio, GTx, Protein Discovery, View Medical, Nanophthalmics, Applied Spine Technologies, Better Walk, AxioMed Spine, TriVirix International, Hapten Sciences, Tidal Wave Technology, ECOSURG, BioSET, Spinal Restoration, Mobilizer, AIS, BioMimetic Therapeutics, SurgiLight, Blood Monitoring Solutions, Inc., Urova Medical, Health & Bliss, Compression Kinetics, CamPlex, Lineus Medical, EndoInSight, KFx Medical, Focal Point Pharmaceuticals, Cuff-Protect, Hubble Telemedical
Gaurav Aggarwal
United States
Dr. Hoyoung Huh is the Founder of pH Pharma and also serves as Co-Chief Executive Officer & Chairman. He also is an Angel Investor. Dr. Hoyoung Huh serves as Managing Partner at Quintessa Investment. He is a Co-Founder and serves as Chairman of the Scientific Advisory Board and Business Development and Director of AntriaBio. He served as Managing Director at Konus Advisory Group. He is the Chairman of the Board of Geron and Cytomx Therapeutics. He serves as a Board Member at Eidos Therapeutics. Additionally, he serves on the board of directors of several privately-held companies. He served as CEO of BiPar Sciences, which was acquired by Sanofi; Director of Facet Biotech acquired by Abbott; Director of Calibra Medical acquired by J&J; Chairman of Epizyme; Director of Addex Pharmaceuticals; Director of EOS acquired by Clovis Oncology; Director and COO of Nektar Therapeutics; and Director of Actogenix acquired by Intrexon. Dr. Huh formerly was a partner at McKinsey & Company and physician-scientist at Cornell University Medical College and Sloan-Kettering Cancer Center. Dr. Huh holds an A.B. in biochemistry from Dartmouth College and an M.D. and Ph.D. in genetics and cell biology from Cornell University Medical College and Sloan-Kettering Institute. He served as Board Member at Ascendancy Healthcare and 4DMT. He also served as a Board Member at Shared-X.
Individual/Angel
Past Investments
Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical, Sinovac Biotech, Visen Pharmaceuticals, IO Biotech, IGM Biosciences, Nabriva Therapeutics, Metacrine, Design Therapeutics, Kira Pharmaceuticals, Cerebral Therapeutics, Medeor Therapeutics, Tarsus Pharmaceuticals, Ascendis Pharma, Serán Bioscience, Innocare, Fortis Therapeutics, Tranquis Therapeutics, SentreHEART, Homology Medicines, Verona Pharma, Bolt Biotherapeutics, Legend Biotech, ASLAN Pharmaceuticals, Citrine Medicine, BlossomHill Therapeutics, ReadCoor, Nora Therapeutics, Immune-Onc Therapeutics, dMed, Akari Therapeutics, Outpost Medicine, Precision BioSciences, Tricida, Crinetics Pharmaceuticals, Harmony Biosciences, Terns Pharmaceuticals, Sierra Oncology, Ventyx Biosciences, Elevation Oncology, MacuLogix, ALX Oncology, TOT BIOPHARM, Impel NeuroPharma, Gracell Biotechnologies, Aclaris Therapeutics, Apellis Pharmaceuticals, Biohaven Pharmaceutical, Amyris, Rongchang Pharmaceutical, Remegen, Gengmei, Celladon, REGENXBIO, PatientPop, Passage Bio, Angiotech Pharmaceuticals, Preventice Solutions, Poseida Therapeutics, Provivi, VYNE Therapeutics, MEI Pharma, Coherus Biosciences, Satsuma Pharmaceuticals, AirXpanders, Genetron Health, Bristol-Myers Squibb, INBRACE, Revolution Medicines, Platelet BioGenesis, Kadmon, Aadi Bioscience, Neocis, Kala Pharmaceuticals, Mereo Biopharma, Arcutis Biotherapeutics, Zai Lab
Gordon Daugherty
United States
Mr. Vishwarupe Narain is a Founder and serves as Chairman and Chief Executive Officer at Pulsar Capital. He also serves as Board Member at Asia Healthcare Holdings. He was a Partner, Managing Director for TPG Growth, a global private equity firm with over $13.5 billion under management, for over ten years and led investments of ~$1 billion in the region. He served on the boards of AGS, a cash management business, Healthium, a global medical device business, American Oncology Institute, an oncology services provider, India Transact, a payments company, Asiri Hospitals, the largest hospital and diagnostic lab business in Sri Lanka, Global Gene Corp, a Singapore based personalized medicine company, Landmark Cars, the leading auto retailer in India, Landmark Insurance, a general insurance broking firm and Dodla Dairy, a leading dairy and milk products company in South India. Prior to joining TPG Growth in 2007, Mr. Narain was an investor with Bessemer Venture Partners in New York. Previous to that, Mr. Narain was an Engagement Manager in McKinsey's Private Equity Practice in Palo Alto and London. Mr. Narain joined McKinsey from Deloitte Consulting, where he was a Senior Consultant. He has an M.B.A. from the Graduate School of Business at Stanford University, a Master of Technology from the Indian Institute of Technology, New Delhi, and a Diploma in Global Leadership and Public Policy from the Kennedy School of Government, Harvard University. Selected as a Young Global Leader in 2014, he is an active member of the World Economic Forum and served on its Advisory Board. He was also nominated as an Aspen Fellow in 2014 and is a member of the Aspen Leadership Institute. He was nominated for Business Today's "40 under 40", and has been featured in several publications including the cover of Forbes India. He has spoken and taught at various institutions including Harvard Business School and the Indian Institute of Management, Ahmedabad.
Individual/Angel
Seed
Past Investments
Chiron Health, Rockify, SwimTopia, Eyeblaster, Written, Pictrition, Famigo, MarketVibe, Riskpulse, Axelo, Embrace, Zing, Mediamind, ROIKOI, Nuve
Gordon Empey
Bellevue, Washington
Partner and General Counsel at Frazier Healthcare Partners
BioTech
ClimateTech/CleanTech
Health & Hospital Services
Health IT
Medical Devices
Pharmaceuticals
Seed
Past Investments
Zeltiq Aesthetics, BARRX Medical, The CORE Institute, Lassen Therapeutics, Zavante Therapeutics, Calistoga Pharmaceuticals, Chimerix, Alnara Pharmaceuticals, Nuon Therapeutics, Stemgent, Moximed, Incline Therapeutics, VentiRx Pharmaceuticals, Calibra Medical, Mirum Pharmaceuticals, Intradigm Corporation, Tarsus Pharmaceuticals, Alpine Immune Sciences, Aptinyx, Alcresta, Barosense, Silvergate Pharmaceuticals, Dascena, Cirius Therapeutics, Outpost Medicine, Rempex Pharmaceuticals, Aspen Neuroscience, Collegium Pharmaceutical, Seraxis, Calibrium, Mavupharma, Inipharm, Sierra Oncology, PatientKeeper, Kalidex Pharmaceuticals, AcertaPharma, Merganser Biotech, AnaptysBio, Sojournix, Iovance Biotherapeutics, Portola Pharmaceuticals, EBR Systems, Imago BioSciences, MBX Biosciences, Vaxcyte, Primaeva Medical, Millendo Therapeutics, Clovis Oncology, Achaogen, Scout Bio, Cadence Pharmaceuticals, Passage Bio, Recida Therapeutics, Amunix, Phathom Pharmaceuticals, Lengo Therapeutics, Tobira Therapeutics, PowerVision, Calypso Medical, Cidara Therapeutics, Semnur Pharmaceuticals, CVRx, Gritstone Oncology, Glaukos, PreCision Dermatology, Threshold Pharmaceuticals, Iterum Therapeutics, Alteon Health, Arcutis Biotherapeutics, Entasis Therapeutics, Allena Pharmaceuticals, Laguna Pharmaceuticals
Harry Barber
New York, New York
Healthcare Investor at Venrock
BioTech
Health IT
Medical Devices
Series B
Series A
Past Investments
Nightfall AI, Biolux Research, Dapper Labs, Constellation Pharmaceuticals, Olema Oncology, Dynamic Signal, Encoded Therapeutics, Interos, Suki, Luma, Simbe Robotics, Iris Medicine, Concentric Analgesics, Skyryse, Mable, Orchard Therapeutics, Quiq, Aledade, Doctor On Demand, Hua Medicine, 3Box, Cyteir Therapeutics, Aria Systems, Chisel.ai, Tricida, Numerated, Astranis, Waybridge, UNITY Biotechnology, Federation Bio, Misty Robotics, Inscripta, Salsify, Running Tide, Renew Health, CrowdJustice, Workframe, Kyruus, Altruist, Auditoria.AI, Devoted Health, Corvidia, Ombud, Atom Computing, Amunix, Lyra Health, Keros Therapeutics, Socrates.AI, Inc., Astronomer, Rebellion Defense, Amino Apps, RefleXion Medical, VelosBio, CTERA Networks, Shape Security, Percipient.ai, Stride Health, CVRx, TAE Technologies, Shockwave Medical, Element Biosciences, Pharvaris, Dstillery, Virta Health, Sitka, ObsEva, 6sense, MakeSchool
Harry George
United States
Mr. Bruce Perkins serves as Strategic Executive at Medical Care Consortium. Mr. Bruce Perkins serves as Board Member & Chairman, Quality of Care Committee at Amedisys. Mr. Perkins, 61, is the Strategic Executive for MCCI Group Holdings, a physician services company based in Miami, Florida ("MCCI Group"). Immediately prior to his January 1, 2015, employment with MCCI Group, Mr. Perkins retired from Humana ("Humana") after a thirty-eight year career, most recently as President of Humana's Healthcare Services Segment. Once Humana spun off its hospital business, Mr. Perkins served as regional vice president and divisional president for Humana health plans across multiple markets. Mr. Perkins was a member of Humana's Management Team. In addition to his MCCI Group responsibilities, Mr. Perkins serves as a strategic advisor and executive coach for ChenMed, a Florida based MSO (and is the parent company of JennCare). He also serves on the Advisory Board of the University of Louisville College of Business and previously served as: chairman of the board of MCCI Group Holdings; a board member of Humana Health Plan of Puerto Rico and Remedi SeniorCare; treasurer of the American Association of PPOs (AAPPO).
Individual/Angel
Past Investments
Evergreen Solar, Protonex Technology Corporation, Sequencia, CellzDirect, Arxan Technologies, HTG Molecular Diagnostics, Splash Pharmaceuticals, E Ink, Astoria Software, PhotoThera, Unveil Technologies, Carefx, MetaCarta, Q1 Labs, CodeRyte, I2 Technologies, Pharsight, Regenesis Biomedical, Supplyworks, AmpliMed Corporation, Connected Corporation, Angstrom Pharmaceuticals, Lumidigm, Archivas, Okena, Lumigent Technologies, Abuzz Technologies
Showing 41 to
60 of
2,855 results